<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05015179</url>
  </required_header>
  <id_info>
    <org_study_id>38/124-25</org_study_id>
    <nct_id>NCT05015179</nct_id>
  </id_info>
  <brief_title>Mixed Reality Technology in Laparoscopic Partial Nephrectomy</brief_title>
  <official_title>Using Mixed Reality Technology to Facilitate Laparoscopic Partial Nephrectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Petersburg State Pavlov Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Saint Petersburg State University, Russia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>St. Petersburg State Pavlov Medical University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of our study was: a) to evaluate the usefulness of the MR model for renal pedicle&#xD;
      exposure and identification of the tumor's exact location during LPN, and b) to evaluate the&#xD;
      subjective utility of the MR model as an intraoperative reference tool.&#xD;
&#xD;
      Investigators prospectively enrolled 47 patients with LPN between June 2020 and February&#xD;
      2021. Patients were randomly assigned into two groups: the control group (24 patients), who&#xD;
      underwent operation with an intraoperative ultrasound (US) control and the experimental group&#xD;
      (23 patients), who underwent operation with the aid of the MR model. Randomization was&#xD;
      performed using a computerized randomization program and sealed envelopes. Patients were&#xD;
      included in the study if they were 18 years of age or older, were able to sign informed&#xD;
      consent, and had T1a renal tumors amenable to LPN. Patients were excluded if they were&#xD;
      unwilling to participate or did not meet the inclusion criteria. For each patient,&#xD;
      investigators prospectively collected demographic data including age, body mass index,&#xD;
      clinical tumor size, side, location, and complexity score according to the PADUA scoring&#xD;
      system; perioperative data (including time for renal pedicle exposure and time for renal&#xD;
      tumor detection and duration of ischemia); pathological data; data on postoperative&#xD;
      functional outcome and complications, classified according to the Clavien-Dindo system.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 1, 2020</start_date>
  <completion_date type="Actual">March 1, 2021</completion_date>
  <primary_completion_date type="Actual">February 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>time required to expose renal pedicle during laparoscopic partial nephrectomy</measure>
    <time_frame>during operation completion, min</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>time required to get from renal pedicle to tumor during laparoscopic partial nephrectomy</measure>
    <time_frame>during operation completion, min</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">47</enrollment>
  <condition>Kidney Tumor</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Laparoscopic partial nephrectomy is performed with an intraoperative ultrasound (US) control</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Underwent Laparoscopic partial nephrectomy with the aid of the mixed reality model</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>mixed reality technology in laparoscopic partial nephrectomy</intervention_name>
    <description>All patients undergo contrast-enhanced computed tomography before surgery. DICOM files are converted to a 3D model. This model is then sent to HoloLens 2 smart glasses using HLOIA software</description>
    <arm_group_label>Experimental</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  able to sign informed consent&#xD;
&#xD;
          -  had T1a renal tumors amenable to LPN&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  were unwilling to participate&#xD;
&#xD;
          -  did not meet the inclusion criteria&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Saint Petersburg State University Hospital</name>
      <address>
        <city>Saint Petersburg</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 7, 2021</study_first_submitted>
  <study_first_submitted_qc>August 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 20, 2021</study_first_posted>
  <last_update_submitted>August 14, 2021</last_update_submitted>
  <last_update_submitted_qc>August 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

